Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders -A retrospective tolerability and safety study

被引：0
|
作者：
Iser, C. [1 ]
Anderson, C. [1 ]
Hirte, I [1 ]
Boddu, S. [1 ]
Girardo, M. [1 ]
Joseph, A. [1 ]
VanderPluym, J. [1 ]
Starling, A. [1 ]
机构：
[1] Mayo Clin, Scottsdale, AZ USA
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-177
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [31] Effectiveness of Peripheral Nerve Blocks for the Treatment of Primary Headache Disorders: A Systematic Review and Meta-Analysis
    Patel, Dilan
    Yadav, Krishan
    Taljaard, Monica
    Shorr, Risa
    Perry, Jeffrey J.
    ANNALS OF EMERGENCY MEDICINE, 2022, 79 (03) : 251 - 261
  • [32] Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Concurrent Cervical Dystonia and Chronic Migraine
    Rhyne, C.
    Martinez, K.
    Stoilova, J.
    Patel, A.
    Ifantides, K. Becker
    Singh, R.
    Yushmanova, I.
    Sadeghi, M.
    Battucci, S.
    Forde, G.
    MOVEMENT DISORDERS, 2023, 38 : S350 - S351
  • [33] Real-world Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients With Concurrent Cervical Dystonia and Chronic Migraine
    Rhyne, Christopher
    Martinez, Kenneth
    Stoilova, Juliana
    Patel, Atul
    Ifantides, Kim Becker
    Singh, Ritu
    Yushmanova, Irina
    Sadeghi, Marjan
    Battucci, Simona
    Grace, Forde
    TOXICON, 2024, 237 : 73 - 74
  • [34] Wear-Off of OnabotulinumtoxinA Effect Over the Treatment Interval in Chronic Migraine: A Retrospective Chart Review With Analysis of Headache Diaries
    Ruscheweyh, Ruth
    Athwal, Bal
    Gryglas-Dworak, Anna
    Frattale, Ilaria
    Latysheva, Nina
    Ornello, Raffaele
    Pozo-Rosich, Patricia
    Sacco, Simona
    Ferrus, Marta Torres
    Stark, Catherine D.
    HEADACHE, 2020, 60 (08): : 1673 - 1682
  • [35] Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
    William B. Young
    J. Ivan Lopez
    John F. Rothrock
    Amelia Orejudos
    Aubrey Manack Adams
    Richard B. Lipton
    Andrew M. Blumenfeld
    The Journal of Headache and Pain, 2019, 20
  • [36] Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
    Young, William B.
    Lopez, J. Ivan
    Rothrock, John F.
    Orejudos, Amelia
    Adams, Aubrey Manack
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
  • [37] OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
    Aurora, S. K.
    Dodick, D. W.
    Diener, H. -C.
    DeGryse, R. E.
    Turkel, C. C.
    Lipton, R. B.
    Silberstein, S. D.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (01): : 61 - 70
  • [38] Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study
    Saper, Joel R.
    Dodick, David W.
    Silberstein, Stephen D.
    McCarville, Sally
    Sun, Mark
    Goadsby, Peter J.
    CEPHALALGIA, 2011, 31 (03) : 271 - 285
  • [39] LONG-TERM SAFETY AND TOLERABILITY OF ONABOTULINUMTOXINA TREATMENT IN CHRONIC MIGRAINE PATIENTS TAKING ORAL PREVENTIVE MEDICATIONS: COMPEL ANALYSIS BY TREATMENT CYCLE
    Winner, P. K.
    Blumenfeld, A. M.
    Eross, E. J.
    Orejudos, A.
    Adams, A. Manack
    Brin, M. F.
    CEPHALALGIA, 2018, 38 : 75 - 76
  • [40] Repeated peripheral nerve blocks reduce cutaneus allodynia symptoms, headache-related disability, depression, and anxiety in chronic migraine
    Ertem, Devrimsel H.
    Tekan, Ulgen Y.
    Altunkaynak, Yavuz
    Uluduz, Derya
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 405 - 406
12345